News

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Press Releases
New drug pricing deal could propel us "light…
Democratic lawmakers in the U.S. Senate advanced drug pricing legislation today that would drastically alter the Medicare program. Dr. Michelle McMurry-Heath, President and CEO of the Biotechnology Innovation Organization (BIO), released…
Do You Know a Game-Changer in the Bioeconomy?…
The Biotechnology Innovation Organization today announced the opening of nominations for two awards to honor significant leaders driving cutting-edge, sustainable breakthroughs in the fields of agriculture and the environment. BIO will accept…
WTO Decision on Waiving Intellectual Property…
Dr. Michelle McMurry-Heath, president & CEO of the Biotechnology Innovation Organization (BIO), released the following statement in response to a decision by the World Trade Organization (WTO) Ministerial Conference (MC12) to endorse a COVID-19…
Letters, Testimony, & Comments
BIO Comments on APHIS Strategic Plan Framework
BIO Comments on FDA Guidance on Improving…
On Monday, June 13th, BIO submitted comments in response to a recently published FDA draft guidance providing recommendations to sponsors on developing a Race and Ethnicity Diversity Plan to enroll adequate numbers of participants in clinical trials…
BIO Sends Letter to Senate Ag Committee…
We write to express our support for the nomination of Oregon Department of Agriculture Director Alexis Taylor to serve as the U.S. Department of Agriculture’s Under Secretary for Trade and Foreign Agricultural Affairs. U.S. agricultural producers…
Amicus Briefs
BIO Files Amicus Brief in Petition for a Writ of…
BIO and AUTM have filed an amicus brief in petition for a writ of certiorari the in American Axle & Manufacturing, Inc., v. Neapco Holdings LLC, et al., at the Supreme Court of the United States. BIO and AUTM are concerned that…
BIO Files Amicus Brief in Support of Rehearing…
BIO files amicus brief in support of a petition for rehearing related to patent-eligibility of diagnostic technology. 
BIO Files Amicus Brief on Case Addressing the…
BIO files an Amicus Brief on rehearing by the Precedential Opinion Panel of the Patent Trial and Appeal Board.
Blog Posts
Placeholder Image
June 7, 2022
Thousands of global biotechnology and biopharmaceutical leaders will gather at the 2022 BIO International Convention in San Diego June 13-16 for four exciting days of networking, programming, and partnering…
primetime life sciences
June 6, 2022
The 2022 BIO International Convention is back and in person this year. Thousands of global biotechnology and biopharmaceutical leaders will gather in San Diego as we celebrate how scientific discoveries and innovations…
Placeholder Image
March 8, 2022
Throughout 2021, there was a great deal of advances in the biotechnology sector in the United States – thanks, in part, to state-led and regional economic development initiatives which have created jobs, advanced…